PTEN is one of the most commonly lost tumor suppressors in human cancer and is known to inhibit insulin signaling. Eph receptor tyrosine kinases (RTKs) have also been implicated in cancer formation and progression, and they have diverse functions, including nervous and vascular system development. We show that in C. elegans, the VAB-1 Eph kinase domain physically interacts with and phosphorylates PTEN (DAF-18), diminishing its protein levels and function. vab-1 mutants show increased longevity and sensitivity to dauer conditions, consistent with increased DAF-18/PTEN activity and decreased insulin-like signaling. Moreover, daf-18 mutations suppress vab-1 oocyte maturation phenotypes independent of PI3K signaling. We also present evidence that DAF-18 has protein phosphatase activity to antagonize VAB-1 action. Possible implications for human cancers are discussed, based on the idea that mutually inhibitory interactions between PTEN and Eph RTKs may be conserved.
INTRODUCTION
The PTEN (phosphatase and tensin homolog deleted on chromosome ten) tumor suppressor is the second most commonly mutated tumor suppressor gene (after p53) in human cancers (Li et al., 1997; Salmena et al., 2008; Steck et al., 1997) . Although mutations that disrupt the PTEN gene are common in cancers, mutation is not a requirement, as many cancers retain wildtype copies of the PTEN gene; however, the PTEN protein is absent from these cells. This suggests that one way PTEN is regulated is at the level of protein stability. Therefore, determining how PTEN is regulated at the protein level is crucial to understanding its role during development and, subsequently, cancer. PTEN is a dual specificity phosphatase and contains both lipid and protein phosphatase activities. Whereas the role of PTEN protein phosphatase is still unclear, it is known that the predominant lipid phosphatase substrate is PIP3, which can activate AKT signaling, leading to increased cell migration and motility. The C. elegans PTEN ortholog is called DAF-18 and has roles in longevity, entry into the dauer larval stage, and arrest of the cell cycle (Fukuyama et al., 2006; Gil et al., 1999; Mihaylova et al., 1999; Ogg and Ruvkun, 1998) . The human PTEN protein can functionally replace DAF-18, suggesting an evolutionary conserved PTEN signaling pathway in humans and C. elegans (Solari et al., 2005) .
The Eph receptors comprise the largest family of receptor tyrosine kinases (RTKs) and play various roles in development, such as embryonic patterning, neuronal targeting, and vascular development during embryogenesis (for reviews, see Klein, 2004; Kullander and Klein, 2002; Lackmann and Boyd, 2008) . Specific families of Eph RTKs and their ephrin ligands are found to be overexpressed in various cancer and tumor cell lines, but their role in cancer is still unclear (Dottori et al., 1999; MerlosSuá rez and Batlle, 2008) . C. elegans possesses one Eph RTK, VAB-1, and its ephrin ligands are required for neuronal signaling during neural and epidermal morphogenesis (Chin-Sang et al., 1999 George et al., 1998; Mohamed and Chin-Sang, 2006) . VAB-1/EphR also plays a role in oocyte maturation, negatively regulating Mitogen-activated protein kinase (MAPK) in developing oocytes (Miller et al., 2003) .
Here, we report genetic and physical interactions between DAF-18/PTEN, and VAB-1/EphR. We show that VAB-1/EphR negatively regulates DAF-18/PTEN in neurons and oocytes during development. Our results provide a mechanistic insight into how these two relatively unrelated proteins function together in various tissues and processes during C. elegans development as well as offer provocative hypotheses regarding how these molecules may be working in higher systems.
RESULTS
VAB-1/EphR Physically Binds DAF-18/PTEN DAF-18/PTEN was identified as an interacting partner of the VAB-1 tyrosine kinase domain in a yeast two-hybrid screen. We screened 3.8 million yeast colonies, and of 55 potential interactions, 5 independent cDNA clones of daf-18/pten were isolated. Through deletion analysis, we have determined that a (327aa) region C-terminal to the phosphatase domain is sufficient to bind the VAB-1 tyrosine kinase domain ( Figure 1A ). To further confirm the interaction, we expressed GST and MBP fusions to DAF-18 and VAB-1 in E. coli and showed that they interact in GST pull-down assays ( Figure 1B) . A mutation that abolishes kinase activity (G912E) is still capable of interacting with DAF-18, indicating that the interaction is kinase independent. The full-length DAF-18 did not show an interaction with VAB-1 in our yeast two-hybrid tests and may explain why a full-length cDNA was not isolated in our Y2H screens. However, we showed that full-length DAF-18 can weakly copurify with the VAB-1 intracellular region in vitro; furthermore, the DAF-18 (C169S or D137A) phosphatase-inactive versions increased its binding to VAB-1, suggesting that the DAF-18/PTEN phosphatase activity may destabilize its binding to VAB-1 ( Figure 1C and data not shown).
VAB-1/EphR and DAF-18/PTEN Are Expressed in Similar Tissues
To follow up on the DAF-18/PTEN and VAB-1/EphR interaction and offer the site of function, we asked whether DAF-18/PTEN and VAB-1/EphR would be localized to similar tissues. Immunohistochemistry experiments reveal that DAF-18/PTEN and VAB-1/EphR are both expressed in the Z2/Z3 germline precursor cells, oocytes, as well as neuronal tissues (Figure 2 ). We utilized two methods to identify DAF-18 expression: endogenous and an overexpressing daf-18 rescuing line (quIs18). Wild-type animals show endogenous DAF-18 expression in the germline precursor cells, Z2/Z3, as well as oocytes (Figures 2B, 2C, and 2G) . In our overexpressing line (quIs18), DAF-18 is also localized to neuronal tissues (2J). VAB-1/EphR is expressed on the membrane (669-985aa shown by a dashed box) was used as bait in yeast two-hybrid assays and identified five independent clones of the daf-18/pten gene (last five shown). The full-length DAF-18 protein does not interact with VAB-1 in yeast two-hybrid assays. The interaction is strongest within the mid region of . The C-terminal end, which has a predicted PDZ-binding motif (PDZbm) appeared to reduce the interaction with VAB-1; relative interaction strength is indicated by ''+,'' weak; ''++,'' medium; ''+++,'' strong lacZ activity. (B) GST pull-down experiments confirm the interaction. The VAB-1 kinase domain fused to GST as well as the VAB-1 kinase-inactive G912E both show equal binding to MBP::DAF-18. Protein expression of GST and GST::VAB-1 is shown below by Coomassie staining. (C) MBP::DAF-18 full-length copurifies with HIS-6::VAB-1 (intracellular). The DAF-18 (D137A) phosphatase-inactivating mutation increased binding to VAB-1. Levels of purified HIS-6::VAB-1 are shown below.
of the proximal oocytes ( Figure 2D ), whereas DAF-18/PTEN appears to show membrane and nuclear expression of multiple oocytes in both hermaphrodites and females ( Figures 2E-2H ). In the neuronal tissues, VAB-1/EphR is localized to the ventral nerve cord, nerve ring, and some head neurons ( Figure 2I ), whereas (quIs18) DAF-18/PTEN's neuronal expression is restricted to a subset of the head amphid neurons and is expressed weakly in the nerve cord. We also detected DAF-18::GFP in the amphids and ventral nerve cord (data not shown). Because of the known interaction with VAB-1/EphR, we asked whether vab-1 mutants can affect the expression pattern of DAF-18 protein. Interestingly, we found that DAF-18 expression is visible in neuronal tissues of vab-1 mutants ( Figure 2L ), similar to our overexpressing lines ( Figure 2M ), whereas endogenous DAF-18 could not be detected in neurons ( Figure 2K ). We also noted that vab-1 increased the strength of expression and the frequency of nuclear expression in oocytes (2F); 81.6% of fem-1(hc17);vab-1(dx31) worms had DAF-18/PTEN in nuclei (n = 60), versus 20.8% of fem-1(hc17) worms (n = 283), further supporting our suspicion that VAB-1/EphR regulates DAF-18/ PTEN.
VAB-1 Negatively Regulates DAF-18/PTEN at the Protein Level
To investigate the form of regulation between the DAF-18/PTEN and VAB-1/EphR interaction, western blots were performed to look at DAF-18/PTEN protein levels. We were able to detect endogenous DAF-18/PTEN in embryo lysates ( Figure 3A ). Wildtype embryos showed low expression of DAF-18/PTEN, whereas our overexpressing DAF-18/PTEN line, quIs18, showed stronger expression (2-fold more). daf-18(ok480) did not have detectable levels of DAF-18/PTEN protein, suggesting this to be a null allele. Interestingly, the vab-1(dx31) null and vab-1(e2) kinase-inactive alleles showed increased DAF-18/PTEN expression compared to wild-type levels (3-fold more), indicating that VAB-1/EphR is a negative regulator of DAF-18/PTEN, and that the kinase activity is required for DAF-18/PTEN regulation ( Figure 3A ). To provide further evidence that VAB-1/EphR has a negative influence on DAF-18 levels, we used an inducible gain-of-function VAB-1. Experiments with a myristoylated VAB-1/EphR under a heat-shock promoter (quIs16) showed that induced VAB-1 can indeed reduce DAF-18 protein levels ( Figure 3B ). Additionally, we found that vab-1(dx31) increased DAF-18 protein in the weak daf-18(e1375) strain ( Figure 3C ). RT-PCR experiments showed that daf-18/pten transcript levels VAB-1 is expressed in at least two of the proximal oocytes, whereas (E and G) DAF-18 is expressed in more than five oocytes in both wild-type and female animals. (F and H) Increased DAF-18 expression is observed in fem-1(hc17);vab-1(dx31) mutants, and nuclear expression is also apparent. (I) VAB-1 is expressed in a variety of neuronal tissues, whereas (J) DAF-18 expression appears to be restricted to several of the amphid neurons. (K-M) DAF-18 protein is not detectable in head neurons of wild-type (WT) animals, but it is present in vab-1(dx31) and in the daf-18 overexpressing line (quIs18).
are not affected in a vab-1(dx31) mutant background ( Figure 3D ). Lastly, in vivo evidence substantiating a negative regulation of DAF-18/PTEN by VAB-1/EphR shows that DAF-18/PTEN expression is not detectable in the nervous system of wild-type L1 larvae, yet is clearly visible in vab-1(dx31) and our overexpressing line, quIs18 ( Figures 2K-2M ). Taken together, our findings show that VAB-1 negatively regulates DAF-18/PTEN at the protein level.
Increased DAF-18/PTEN Expression Confers Increased Longevity and Sensitivity to Dauer Larva Conditions Since inhibition of DAF-2/insulin-like receptor and AGE-1/PI3K signaling leads to increased longevity and sensitivity to dauer conditions, we hypothesized that increased DAF-18/ PTEN expression should show similar results to daf-2 and age-1 mutants, as DAF-18/PTEN has been shown to reduce PI3K signaling by dephosphorylation of PIP3 (Solari et al., 2005) . Furthermore, if VAB-1/EphR is a negative regulator of DAF-18/ PTEN, we would expect that vab-1(dx31) might show a similar phenotype to our overexpressing DAF-18/PTEN animals. Longevity and dauer larva studies supported our hypothesis that overexpression of DAF-18/PTEN does lead to increased life span and sensitivity to dauer conditions (Figure 4) . fem-1(hc17);vab-1(dx31) and fem-1(hc17);quIs18 have significantly longer life spans than fem-1(hc17) ( Figure 4A ). The fem-1(hc17) mutant was used to eliminate the need for daily transfers of counted worms away from their progeny and does not have an effect on life span (Glenn et al., 2004) . Also consistent with increased DAF-18 signaling, we found that worms expressing elevated levels of DAF-18 were more sensitive to dauer conditions than wild-type. vab-1(dx31) and quIs18 formed dauers more frequently on daf-2 RNAi at 25 C compared to wild-type ( Figure 4B ). The increased dauer sensitivity was also observed in vab-1(dx31) and quIs18 animals at 27 C, where vab-1(dx31) and quIs18 animals formed significantly more dauers than N2 wild-type (N2 = 54%, vab-1(dx31) = 93%, quIs18 = 82%). This temperature has been shown to induce dauer in some strains during nonstarvation/noncrowding conditions (Ailion and Thomas, 2000) .
DAF-18/PTEN Functions Downstream of VAB-1 in Oocyte Maturation
Because DAF-18/PTEN was observed to be expressed in oocytes ( Figure 2G ), we questioned whether it may have a role in oocyte maturation, like VAB-1/EphR (Miller et al., 2001 (Miller et al., , 2003 . We noticed that vab-1(dx31) animals seemed to be laying a disproportionate number of unfertilized oocytes ( Figure 5A ). It has been suggested that vab-1 lays increased numbers of unfertilized oocytes after 60 hr of egg laying and may be due to a lack of sperm availability (Miller et al., 2003) . When we looked at the total number of oocytes laid over the course of 3 days, we found that vab-1(dx31) animals laid significantly more unfertilized oocytes than wild-type animals, and that the daf-18(ok480) mutation was able to return this phenotype to wild-type levels ( Figure 5B ). To test whether VAB-1/EphR is regulating DAF-18/ PTEN through the canonical insulin signaling pathway, we asked whether mutations in age-1/PI3K would lead to an increased unfertilized oocyte phenotype, like vab-1 mutants, or whether daf-16/FOXO could suppress the vab-1 oocyte defect. age-1 (m333) loss-of-function mutants did not show increased oocyte laying, and, moreover, daf-16(mu86) did not suppress the vab-1 (dx31) increased oocyte laying defect, suggesting that DAF-18/ PTEN functions independent of the insulin signaling pathway in oocyte maturation ( Figure 5D ). To determine whether this increase in oocyte laying was only occurring after 60 hr of egg laying and when the sperm was depleted, we performed a day-by-day breakdown of unfertilized oocytes laid ( Figure 5E ). Our results show that after 24 hr of egg laying, vab-1(dx31) animals laid significantly more oocytes than vab-1(dx31);daf-18 (ok480) animals; thus, it is not completely due to a depletion of sperm, as unfertilized embryos are also visible among fertilized embryos in vab-1(dx31) animals prior to 60 hr of egg laying ( Figure 5C ). The laying of increased unfertilized oocytes can be explained by ovulation rate, as vab-1(dx31) animals have a significantly higher ovulation rate than wild-type ( Figure 5F ) (Miller et al., 2003) . Furthermore, the daf-18(ok480) mutation returns the ovulation rate of vab-1(dx31) to near wild-type rates.
As activated MAPK expression has been related to oocyte maturation, with vab-1 mutants displaying increased MAPK expression, we questioned whether DAF-18/PTEN may have a role in MAPK regulation during oocyte maturation. Interestingly, antibody staining against activated MAPK revealed that expression was decreased in daf-18/pten mutants ( Figure 5G ), suggesting that DAF-18/PTEN may be a positive regulator of MAPK in oocytes. Additionally, daf-18(ok480) was able to suppress the increased MAPK expression phenotype observed in vab-1 (dx31) mutants ( Figure 5G ). These findings provide good genetic evidence for the interaction between DAF-18/PTEN and VAB-1/ EphR and offer a role for DAF-18/PTEN in oocyte maturation outside of the DAF-2/insulin receptor-like signaling pathway. Figure 6A, lanes 1 and 3) . In contrast, VAB-1 did not have tyrosine kinase activity on full-length DAF-18 protein. We also noticed that the autophosphorylation level of VAB-1 is reduced greatly when full-length DAF-18 is coexpressed with VAB-1, indicating that DAF-18 may have tyrosine phosphatase activity on VAB-1 ( Figure 6A , lane 2). To test this idea, we used a site-directed mutagenesis approach to make DAF-18 phosphatase-inactive versions: DAF-18 (C169S) and DAF-18 (D137A). The DAF-18 (C169S) mutation is analogous to the human PTEN (C124S) and abolishes lipid and protein phosphatase activity (Myers et al., 1998; Tamura et al., 1998) , whereas the DAF-18 (D137A) mutation is analogous to PTEN (D92A), which reduces the protein-tyrosine phosphatase, but retains its ability to bind substrates (also known as ''phosphatase trap'') (Tamura et al., 1999) . Indeed, the DAF-18 (C169S) and DAF-18 (D137A) (not shown) phosphatase-deficient proteins did not reduce the VAB-1 autophosphorylation levels to that caused by wild-type DAF-18, suggesting that DAF-18 does have VAB-1 protein tyrosine phosphatase activity ( Figure 6A ). To provide in vivo evidence for DAF-18/PTEN tyrosine phosphatase activity, we showed that DAF-18 can reduce VAB-1 tyrosine kinase activity in C. elegans neurons. Mohamed and Chin-Sang (2006) previously showed that a hyperactive tyrosine kinase version of VAB-1 (MYR-VAB-1) expressed from the mec-4 promoter caused strong PY levels in the touch (mechanosensory) neurons ( Figure 6C ). The increased VAB-1 kinase activity caused neuronal defects, including premature axon termination defects (Mohamed and Chin-Sang, 2006) . Note that the touch neurons do not stain for PY in wild-type worms, and that PY detection is dependent on the MYR-VAB-1 tyrosine kinase activity ( Figure 6D ). We reasoned that if DAF-18 has tyrosine phosphatase activity on VAB-1, then it would reduce MYR-VAB-1 PY levels. When we expressed mec-4::DAF-18 specifically in the touch neurons, we found that the majority of animals expressing DAF-18 (23 out of 40) caused a dramatic decrease in MYR-VAB-1-induced PY ( Figure 6E ). In addition, the expression of DAF-18 was able to partially suppress the neuronal defects caused by MYR-VAB-1. Full suppression was not expected, as overexpression of DAF-18 in the touch neurons also displayed neuronal defects ( Figure 6F and data not shown). In other cases, MYR-VAB-1 tyrosine kinase activity still persisted in neurons, even though the animals carried the mec-4::DAF-18 transgene. The levels of DAF-18 protein in these neurons, however, were much lower, suggesting that constitutively active MYR-VAB-1 could downregulate DAF-18 protein in neurons ( Figures 6H-6J ). The fact that the kinase-inactive vab-1(e2) allele had similar effects on increasing the DAF-18/PTEN protein levels ( Figure 3A ) provides in vivo evidence that the kinase activity of VAB-1 is indeed required for regulating the levels of DAF-18/PTEN. Taken together, our results suggest that the DAF-18/PTEN tyrosine (B) vab-1(dx31) and quIs18 formed significantly more dauer larva than wildtype on daf-2 RNAi (*p < 0.01). A total of 14.01% ± 1.02% of vab-1(dx31) (n = 1577) and 45.0% ± 2.371% (n = 1102) of quIs18 formed dauer larva on daf-2 RNAi at 25 C compared to 4.95% ± 0.66% of wild-type (n = 1778).
phosphatase and the VAB-1 tyrosine kinase can act as substrates for each protein to inhibit each other's activity.
DISCUSSION
We show that the C. elegans Eph RTK VAB-1/EphR binds to and phosphorylates DAF-18/PTEN. DAF-18/PTEN also exhibits protein phosphatase activity on VAB-1. We provide genetic evidence that VAB-1 has a negative influence on DAF-18/ PTEN protein levels, leading to increased insulin-like signaling. In addition, DAF-18/PTEN has a role in oocyte maturation downstream of VAB-1/EphR signaling independent of AGE-1/PI3K signaling.
VAB-1/EphR Negatively Regulates DAF-18/PTEN at the Protein Level DAF-18 and PTEN both inhibit the insulin/PI3K signaling pathway, leading to the inhibition of AKT phosphorylation of the FOXO transcription factor, and, accordingly, are involved in dauer formation and longevity in C. elegans and in tumor suppression and apoptosis in mammalian cells (Di Cristofano and Pandolfi, 2000; Gil et al., 1999; Mihaylova et al., 1999; Ogg and Ruvkun, 1998; Pinkston et al., 2006 (Vazquez et al., 2000 (Vazquez et al., , 2001 . Similarly, in our model ( Figure 7A ), VAB-1/EphR phosphorylates DAF-18/ PTEN, deactivating it, resulting in increased insulin signaling. An ''electrostatic switch'' model of phosphorylation/dephosphorylation of PTEN's C-terminal region has been proposed as a mechanism of recruiting and activating PTEN at the cell membrane (Das et al., 2003) . Although PTEN phosphorylation/ dephosphorylation typically occurs on serine/threonine 
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Eph RTK Regulates PTEN residues, our work on DAF-18 tyrosine phosphorylation provides another mode of regulation for PTEN. Our work on an Eph RTK also supports previous in vitro work that suggested Src kinases may have a tyrosine phosphorylation-induced degradation of PTEN, and this may contribute to the effects of Src on tumorgenesis (Lu et al., 2003) . However, the regulation of PTEN by tyrosine phosphorylation is complex, as the Rak tyrosine kinase (a member of the Src tyrosine kinase family) can phosphorylate PTEN to protect it from ubiquitin-mediated degradation (Yim et al., 2009 ). These opposing activities of PTEN tyrosine phosphorylation highlight the need for further work on other tyrosine kinases and their specific effects on PTEN protein stability. We also show that, in neurons, DAF-18/PTEN has tyrosine phosphatase activity on the VAB-1/EphR, reducing its forward signaling. This protein tyrosine phosphatase activity is reminiscent of reports that suggested that the platelet-derived growth factor receptor (an RTK) is inactivated by PTEN tyrosine phosphatase activity (Mahimainathan and Choudhury, 2004) , and that the PTEN tyrosine phosphatase activity can also inhibit FAK tyrosine phosphorylation (Tamura et al., 1998) . A common theme is emerging that PTEN tyrosine phosphatase activity may have inhibitory roles on specific tyrosine kinases.
The Localization of VAB-1/EphR and DAF-18/PTEN Gives Insight into Their Function in C. elegans
The presence of DAF-18/PTEN in the amphid neurons is intriguing, as they represent the sensory organs of C. elegans, allowing for detection of changes in the external environment (Ashton et al., 1999) . In particular, the ADF and ASI amphid neurons function to control entry into dauer (Perkins et al., 1986) . As such, it is likely that DAF-18 is expressed in at least these two amphid neurons. DAF-18 is also reported to function with DAF-2 and AGE-1 in ASER to regulate salt chemotaxis (Tomioka et al., 2006) . Although VAB-1's neural expression is not restricted to the amphid neurons, it is known to be present in nervous tissues (Chin-Sang et al., 1999; George et al., 1998) and is consistent with regulating DAF-18/PTEN in the amphid subset of head neurons. 
versus [F]). (G) A merged image of (E) and (F).
(H and I) In some neurons, overexpression of DAF-18 was not able to reduce MYR-VAB-1 PY levels, and, instead, the MYR-VAB-1-expressing neuron had the effect of reducing the DAF-18/PTEN protein level in that neuron. Arrow points to the right ALM, showing high MYR-VAB-1 activity (red) but low DAF-18 protein (green).
Interestingly, we found that DAF-18 nuclear expression was more apparent in a vab-1(dx31) background. Whereas there has not been a published role for nuclear DAF-18, PTEN has been shown to have some nuclear function, such as forming a nuclear complex with p53, increasing the transcriptional activity of p53, and having nuclear effects independent of phosphatase activity (Freeman et al., 2003) . As VAB-1/EphR is a transmembrane receptor, it could be that VAB-1/EphR sequesters DAF-18/PTEN to the membrane, whereas in the absence of VAB-1/EphR, localization to the nucleus is more permissible. PTEN cellular function has been found to be dependent on its localization; cytoplasmic PTEN is primarily involved in AKTmediated pathways associated with apoptosis, whereas nuclear PTEN is AKT independent and induces G 0 -G 1 cell cycle arrest (Chung et al., 2006; Liu et al., 2005) .
The DAF-18/PTEN and VAB-1/EphR Interaction Introduces Developmental Roles for Eph Receptor Signaling in C. elegans Our analysis of the DAF-18/PTEN and VAB-1/EphR interaction proposes other functions for each protein in C. elegans. By identifying VAB-1/EphR as a negative regulator of DAF-18/PTEN, we have placed an Eph receptor as a potential modifier of insulin signaling, controlling longevity and entry into dauer ( Figure 7A ). The vertebrate EphA-ephrinA bidirectional signaling has been implicated in modulating insulin secretion from b-cell pancreatic islets; forward EphA5 signaling inhibits insulin secretion, whereas reverse ephrinA5 signaling stimulates insulin secretion in response to glucose (Konstantinova et al., 2007) . Our results in C. elegans show an Eph receptor having positive influence on insulin signaling through downregulation of DAF-18/PTEN and are consistent with a negative-feedback mechanism whereby increased insulin signaling reduces insulin secretion.
In C. elegans, oocytes are held in meiotic arrest prior to fertilization, upon which a sequence of signaling events for oocyte maturation occurs, initiated by binding of the Major Sperm Protein (MSP) to the VAB-1/EphR (Miller et al., 2001 (Miller et al., , 2003 McCarter et al., 1997) . In the absence of vab-1, oocyte maturation is deregulated, leading to increased ovulation and MAPK activation in multiple oocytes (Corrigan et al., 2005; Miller et al., 2003) . Our observation that daf-18/pten can rescue the oocyte maturation defects displayed by vab-1/EphR gives DAF-18/PTEN a role in this developmental process downstream of VAB-1/EphR. Since age-1 mutant animals do not show increased oocyte maturation, and daf-16 mutants do not suppress vab-1's oocyte defects, we have thus placed DAF-18 between VAB-1 and MAPK in the pathway initiating oocyte maturation and independent of the canonical insulin pathway ( Figure 7B ). Interestingly, Reddy et al. (2008) reported a role for PTEN function in mammalian oocytes, during follicle activation. However, overexpressing PI3K or AKT in oocytes does not affect follicular development or oocyte maturation, suggesting that PTEN has a stage-specific function or it functions in a PI3K-independent manner during mammalian oocyte maturation (Jagarlamudi et al., 2009). Previous work in C. elegans has implicated daf-18 in oocyte maturation, as mutations in daf-18/pten enhance the endomitotic phenotype of ceh-18, a POU-class, homeodomain-containing transcription factor that regulates gonadal sheath differentiation (Suzuki and Han, 2006) . Suzuki and Han postulated that daf-18 may act with ceh-18 to regulate ovulation to inhibit MAPK. They suggest that DAF-18 may have a negative influence on MAPK expression through PIP2:PIP3 ratios or the AKT kinases. Although their proposed model of DAF-18 action in oocytes varies from ours, differences in how the experiments were done may account for the disparity between the results. Suzuki and Han used worms that were starved as L1s and analyzed unmated females, and vab-1 RNAi was used instead of vab-1 mutants. The differences in MAPK activity in females versus hermaphrodites could account for the differences in activated MAPK in daf-18 mutants. Indeed, it was reported previously that the activated MAPK is not increased in vab-1 females, and the oocyte maturation defect seen in vab-1 mutants is only present in hermaphrodites or when sperm protein is introduced to females (Miller et al., 2003) . Therefore, in our analysis, we used hermaphrodites (sperm present) to specifically look at the levels of activated MAPK in vab-1 and vab-1;daf-18 doubles. While it may be counterintuitive to consider DAF-18/PTEN a positive regulator of MAPK based on the traditional holding that PTEN attenuates MAPK activity (Chung et al., 2006; Mahimainathan and Choudhury, 2004; Weng et al., 2002) , it does corroborate our model for the VAB-1/ EphR interaction and account for the reduced ovulation rates displayed by daf-18(ok480) and vab-1(dx31);daf-18(ok480) animals. The result that DAF-18/PTEN may function as a positive regulator of MAPK in C. elegans oocytes is also supported by other work. Shen and colleagues report that upregulation of PTEN is associated with increased p38 MAPK activity during stress-induced inhibition of insulin signaling and may account for the insulin resistance observed in some metabolic disorders (Shen et al., 2006) . Additionally, studies in C. elegans revealed that decreased DAF-2 insulin-like signaling caused activation of MAPK, which leads to protein degradation in striated muscle (Szewczyk et al., 2007) . Therefore, although divergent from the conventional role of MAPK regulation, these findings highlight the importance of investigating protein regulation and function from multiple perspectives, and the importance of defining signaling pathways based on cellular context. In summary, we have shown that VAB-1, the C. elegans Eph RTK, and DAF-18/PTEN proteins are substrates for each other and have mutually antagonistic roles on each other's function. Numerous cancer types have been shown to have increased Eph receptor expression, but the downstream signaling mechanisms are unknown. Our results are significant, as they propose developmental roles for VAB-1/EphR and DAF-18/PTEN in C. elegans, and also offer potential avenues for further research in the mammalian system.
EXPERIMENTAL PROCEDURES
Genetic Analysis C. elegans strains were cultured as described by Brenner (1974) at 20 C unless otherwise noted. Strains used in this study were as follows: N2 wild-type, CZ337 vab-1(dx31), RB712 daf-18(ok480), CB1375 daf-18(e1375), IC804 vab-1(dx31); daf-18(ok480), IC218 vab-1(dx31); daf-18(e1375) ] (Mohamed and Chin-Sang, 2006 ; this study).
Constructs and Transgenic Lines
To generate the overexpressing DAF-18 strain, quIs18, a 7.8 kb genomic daf-18 PCR product from wild-type genomic DNA was coinjected with pRF-4 and psur-5::GFP into daf-18(ok480) mutants (all 30 ng/ml). This construct is able to rescue the daf-18(ok480) dauer and life span phenotype (results not shown). This line was outcrossed to wild-type to eliminate the daf-18(ok480) background and then integrated by following a TMP/UV protocol. To generate the HS MYR::VAB-1(quIs16), we incorporated the c-Src N-terminal myristoylation (MYR) signal (MGSSKS) in a PCR primer to produce a 1.6 kb myr-vab-1 product identical to that used in the quIs5 [mec-4::myr-vab-1] strain (Mohamed and Chin-Sang, 2006) . The myr-vab-1 was cloned into pPD49.83 (A. Fire), a heat-shock vector containing the HS16-41 heat-shock promoter. This construct was coinjected with HS16-41::GFP and an odr-1::RFP plasmid (all 30 ng/ml) into N2 worms. Extrachromosomal array lines were obtained, and a stable chromosomal integration by TMP/UV was used to establish quIs16. All constructs were verified by sequencing.
Yeast Two-Hybrid Assays Yeast were grown on standard complete and selective media, as appropriate (Sherman, 1991) . Yeast transformation was performed by using a lithium acetate method (Schiestl and Gietz, 1989) . The 1.6 kb fragment encoding the kinase domain (669-985 aa) of VAB-1 was amplified from vab-1 cDNA and cloned into the GAL4 DNA-Binding domain, pAS1, to act as bait in the C. elegans cDNA library. For deletion analysis, pGBKT7 and pGADT7/pACT were used as bait and prey cloning vectors, respectively. Primer sequences and details of plasmid constructs are available upon request.
GST Pull-Down and Copurification Assays pIC-104, a cDNA encoding the vab-1 intracellular region (581-1117 aa), was cloned in frame to glutathione-S-transferase (pGEX4T-2, Amersham), and pIC-263, a vab-1(e2) (G912E) kinase-dead mutation, was created using the QuikChange Site-Directed Mutagenesis Kits (Stratagene). pIC-73, a cDNA encoding the DAF-18 Mid region (406-835 aa) was fused in frame to MaltoseBinding Protein (pMALp2, New England Biolabs). All these fusion constructs were expressed in E. coli Tuner (DE3). Soluble extract containing MBP::DAF-18 (Load) was incubated for 2 hr at 4 C with soluble extract containing either GST (3 mg/ml), GST::VAB-1, or GST::VAB-1(G912E) (0.25 mg/ml) bound to 40 ml glutathione resin beads (GST-Bind, Novagen). Unbound fractions were collected, protein bound to beads was washed four times (25 mM Tris-Cl [pH 7.5], 150 mM NaCl, 1 mM DTT, 10% glycerol, 0.5% Triton X-100), and a proportional loading of each was analyzed by SDS-PAGE followed by western blot. MBP::DAF-18 was detected by using anti-MBP conjugated to HRP (New England Biolabs) followed by ECL (Pierce). For the copurification assays, pIC-582 HIS-6::VAB-1 was coexpressed with either pIC-227 (MBP::DAF-18 full-length WT), pIC-583 (MBP::DAF-18 full-length C169S), or pIC-637 (MBP-DAF-18 full-length D137A). HIS-6::VAB-1 was purified on nickel resin, and a portion was run on SDS-PAGE and probed with anti-DAF-18 or MBP to detect MBP::DAF-18 binding. MBP::DAF-18 (406-835 aa) also copurified with HIS-6:: VAB-1, whereas MBP alone did not (data not shown). The blot was stripped and reprobed for VAB-1 to show protein levels of purified HIS-6::VAB-1.
Immunohistochemistry

Mixed-Stage Staining
Antibody staining was carried out as described by Chin-Sang et al. (1999) . Anti-GST::DAF-18 and anti-VAB-1:HIS-6 antibodies (rabbit hosts were produced by Covance, Inc.) were visualized with secondary FITC-anti-rabbit antibodies (Upstate/Millipore).
Gonad Staining
A total of 30-40 L4 larvae were allowed to develop to young adults overnight at 20 C. Worm gonads were dissected and placed onto GCP (gelatin, chromium potassium sulfate, poly-L-lysine)-coated slides, and a coverslip was applied diagonally and immersed in liquid nitrogen. Slides were then fixed by a methanol/acetone fixation procedure described by Strome and Wood (1983) . Gonads were probed with monoclonal antibody for activated MAP kinase, Activated (Sigma, M 9692), followed by secondary FITC-anti-mouse antibodies (Chemicon).
Western Blot
Protein lysates were made by plating 10-20 young adults on individual plates (3 plates per strain); adults were then allowed to lay F1 progeny at 15 -20 C.
The F1s were bleached to recover embryos ( Figures 3A and 3B ) or mixedstage lysed ( Figure 3C ) with 23 Sample buffer + DTT, and proteins were separated on 10% SDS-PAGE, western blotted, and probed with anti-DAF-18 antibodies and secondary HRP-anti-rabbit antibodies (Upstate/Millipore). Monoclonal antibodies against actin (Clone C4, MP Biomedicals) were used as a loading standard, and relative band intensities were calculated by using the National Institute's of Health Image J program.
Kinase/Phosphatase Assays VAB-1 and DAF-18 fusion proteins were coexpressed by using the pCOLADuet-1 vector system (Novagen) that allows for the inducible expression of two plasmids within a single E. coli cell. VAB-1 constructs pIC-549 MBP::VAB-1(581-1117 aa) or pIC-551 MBP::VAB-1(G912E) were coexpressed with either pIC-227 (MBP::DAF-18 full-length), pIC-73 (MBP::DAF-18 406-835 aa), pIC-583 (MBP::DAF-18 full-length C169S), or pIC-637 (MBP:: DAF-18 full-length D137A). Proteins were induced, and total protein lysates were run on SDS-PAGE followed by western blot with the anti-phosphotyrosine antibody 4G10 (Millipore/Upstate).
RT-PCR
RNA extraction was performed by using the Promega SV Total Isolation System according to the manufacturer's protocol. A total of 100 ml of mixedstage worm pellet was utilized for each strain. Reverse transcription was carried out with the New England Biolabs Protoscript II RT-PCR Kit. Region 576-2488 nt was used for daf-18 cDNA amplification.
Oocyte Maturation Assay
In a procedure adapted from Miller et al. (2001) , L4 larvae were picked to plates and allowed to mature into young adults overnight at 20 C. The number of oocytes/embryos present in the spermatheca/uterus was counted with the Zeiss Axiovert 200M at 103 magnification. The worms were then allowed to lay eggs for 5 hr at 20 C. The number of eggs retained in the spermatheca/ uterus was counted, as well as the number of eggs laid on the plate. Ovulation rate was determined by taking the number of eggs retained originally and subtracting it from the number of eggs retained after 5 hr plus the number of eggs laid during the 5 hr period. The average number of embryos/oocytes ovulated in 1 hr and per gonad arm was then calculated.
Oocyte and Embryo Counts
Oocyte and embryo counts were performed by picking 6-7 L4 hermaphrodites as well many individual L4 worms (5-20 individuals for brood profiles; data not shown) to E. coli seeded plates. Worms were transferred to new seeded plates every 24 hr for 3 days, and plates were scored for the number of embryos and oocytes laid. If L1 larvae were present, they were counted as a laid embryo. The numbers of fertilized eggs and oocytes laid from both multiworm and individual worm plates were pooled together to give sample size (n).
Dauer Assays: daf-2 RNAi and 27 C Experiment daf-2 RNAi daf-2 RNAi was generated by cloning a 1.9 kb fragment of daf-2 into the L4440 feeding vector and transforming into HT115(DE3) competent cells. daf-2 RNAi bacteria was plated out on NGM plates containing Amp (50 mg/ml) and IPTG (0.4 mM) and was allowed to grow overnight. Strains utilized were synchronized as L1s and then plated onto daf-2 RNAi plates (100/plate) and stored at 25 C. The number of dauer larvae was scored after 48 hr at 25 C.
Assay
vab-1(dx31), quIs18, and wild-type were synchronized in M9 buffer at 20 C, and L1s were plated onto E. coli seeded plates at 27 C. After 48 hr, strains were scored for dauer versus non-dauer larvae, and the percentages of dauer formed were calculated as described in Ailion and Thomas (2000) .
Life Span Assays
Life span assays were carried out as described by Glenn et al. (2004) . vab-1(dx31) and quIs18 (genomic daf-18) were crossed into a fem-1(hc17) background to eliminate the need for daily transfers away from progeny. quIs18; , and fem-1(hc17) worms raised at 15 C were synchronized, and L1s were plated out onto E. coli-seeded plates and then shifted to 25 C to develop as females. At L2/L3, ten worms per seeded plate were picked, and survival was scored every 2 days as a response to prodding.
